Kestrel Therapeutics News and Activities

View the org chart displaying its 14 main executives

Most searched biographies at Kestrel Therapeutics

• Frank Haluska, President & Chief Executive Officer
• Omar Khalil, Director
• Tom Phair, Chief Financial Officer

Create your alert
to follow the executive moves at Kestrel Therapeutics.

Kestrel Therapeutics has 2,347 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Johnson & Johnson Innovative Medicine DIA (United States (USA)).

Popular M&A news in Biotechnology

• Attovia Therapeutics has just announced a $90 Million fundraising (posted on April 21 2025).
• Transcarent and Accolade have merged  (posted on April 9 2025)..
• Kashiv BioSciences has just announced a $150 Million fundraising (posted on April 7 2025).

Popular contacts in Biotechnology

• Kristina Burow - Director at Scholar Rock
• Steven Gillis - Chairman of the Board at VBI Vaccines
• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics

Learn more about the Biotechnology industry

Press releases by Kestrel Therapeutics

• News Archives - Kestrel Therapeutics

Social media about Kestrel Therapeutics

• Kestrel Therapeutics on Wikipedia, Google News & Yahoo Finance
• Kestrel Therapeutics on LinkedIn, Twitter & YouTube